Hepatic Impairment Study for Lorlatinib in Cancer Patients
Condition(s):Advanced CancersLast Updated:January 26, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Advanced CancersLast Updated:January 26, 2022Terminated
Condition(s):Hepatic ImpairmentLast Updated:October 24, 2013Completed
Condition(s):Hepatic Impairment; Liver Diseases; Digestive System DiseasesLast Updated:February 24, 2016Completed
Condition(s):Heptic ImpairmentLast Updated:March 18, 2015Completed
Condition(s):Severe Hepatic ImpairmentLast Updated:November 6, 2020Completed
Condition(s):Healthy; Hepatic ImpairmentLast Updated:March 2, 2023Completed
Condition(s):Hepatic ImpairmentLast Updated:March 16, 2022Completed
Condition(s):Type 2 Diabetes Mellitus; Hepatic ImpairmentLast Updated:August 20, 2018Completed
Condition(s):Hepatic ImpairmentLast Updated:March 18, 2024Recruiting
Condition(s):Digestive System DisordersLast Updated:October 16, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.